The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

被引：0
|
作者：
C. J. Currie
C. D. Poole
E. A. M. Gale
机构：
[1] Cardiff University,School of Medicine
[2] The Pharma Research Centre,Department of Epidemiology
[3] Cardiff MediCentre,Diabetes and Metabolism, School of Medicine
[4] Pharmatelligence,undefined
[5] Bristol University,undefined
来源：
Diabetologia | 2009年 / 52卷
关键词：
Cancer; Insulin; Insulin analogues; Metformin; Sulfonylureas; Survival; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1766 / 1777
页数：11
相关论文
共 50 条
  • [21] Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes
    Zanders, Marjolein M. J.
    Haak, Harm R.
    van Herk-Sukel, Myrthe P. P.
    van de Poll-Franse, Lonneke V.
    Johnson, Jeffrey A.
    DIABETOLOGIA, 2015, 58 (05) : 951 - 960
  • [22] Use of Glucose-Lowering Agents in Diabetes and CKD
    Alicic, Radica Z.
    Neumiller, Joshua J.
    Galindo, Rodolfo J.
    Tuttle, Katherine R.
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (12): : 2589 - 2607
  • [23] Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes
    Cristina Bianchi
    Giuseppe Daniele
    Angela Dardano
    Roberto Miccoli
    Stefano Del Prato
    Drugs, 2017, 77 : 247 - 264
  • [24] Mining treatment patterns of glucose-lowering medications for type 2 diabetes in the Netherlands
    van den Heuvel, Jan Maurik
    Farzan, Niloufar
    van Hoek, Mandy
    van der Zee, Anke-Hilse Maitland
    Ahmadizar, Fariba
    BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
  • [25] Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes
    Holman, Rury R.
    Sourij, Harald
    Califf, Robert M.
    LANCET, 2014, 383 (9933) : 2008 - 2017
  • [26] Glucose-Lowering Therapies and Heart Failure in Type 2 Diabetes Mellitus Mechanistic Links, Clinical Data, and Future Directions
    Vijayakumar, Shilpa
    Vaduganathan, Muthiah
    Butler, Javed
    CIRCULATION, 2018, 137 (10) : 1060 - 1073
  • [27] Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes
    Preiser, Jean-Charles
    Provenzano, Bruna
    Mongkolpun, Wasineeart
    Halenarova, Katarina
    Cnop, Miriam
    ANESTHESIOLOGY, 2020, 133 (02) : 430 - 438
  • [28] The Glucose-lowering Efficacy of Sitagliptin in Obese Japanese Patients with Type 2 Diabetes
    Kodera, Ryo
    Shikata, Kenichi
    Nakamura, Akihiko
    Okazaki, Satoru
    Nagase, Ryo
    Nakatou, Tatsuaki
    Haisa, Shigeru
    Hida, Kazuyuki
    Miyashita, Katsuhiro
    Makino, Hirofumi
    INTERNAL MEDICINE, 2017, 56 (06) : 605 - 613
  • [29] Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes
    Ahren, Bo
    VASCULAR HEALTH AND RISK MANAGEMENT, 2013, 9 : 155 - 163
  • [30] Effect of glucose-lowering therapies on heart failure
    Nassif, Michael
    Kosiborod, Mikhail
    NATURE REVIEWS CARDIOLOGY, 2018, 15 (05) : 282 - 291
12345